1. Home
  2. MEI vs CERS Comparison

MEI vs CERS Comparison

Compare MEI & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Methode Electronics Inc.

MEI

Methode Electronics Inc.

N/A

Current Price

$14.27

Market Cap

581.1M

Sector

Technology

ML Signal

N/A

Logo Cerus Corporation

CERS

Cerus Corporation

N/A

Current Price

$2.30

Market Cap

534.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MEI
CERS
Founded
1946
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
EDP Services
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
581.1M
534.0M
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
MEI
CERS
Price
$14.27
$2.30
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
★ $22.00
$5.13
AVG Volume (30 Days)
631.8K
★ 1.5M
Earning Date
09-02-2026
11-05-2026
Dividend Yield
★ 1.45%
N/A
EPS Growth
★ 42.94
27.27
EPS
N/A
★ N/A
Revenue
★ $908,300,000.00
$51,326,000.00
Revenue This Year
$4.13
$20.82
Revenue Next Year
$5.76
$9.02
P/E Ratio
N/A
★ N/A
Revenue Growth
11.24
★ 30.68
52 Week Low
$4.88
$1.38
52 Week High
$20.38
$3.47

Technical Indicators

Market Signals
Indicator
MEI
CERS
Relative Strength Index (RSI) 44.10 35.19
Support Level $12.68 $2.05
Resistance Level $15.56 $2.69
Average True Range (ATR) 0.70 0.10
MACD 0.04 -0.02
Stochastic Oscillator 30.99 0.28

Price Performance

Historical Comparison
MEI
CERS

About MEI Methode Electronics Inc.

Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, with the majority of revenue from Europe, the Middle East & Africa (EMEA).

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

Share on Social Networks: